Francisco Javier Hidalgo-Tallón1*
Luis Miguel Torres-Morera2Jose Baeza-Noci3Maria Dolores Carrillo-Izquierdo4Rosa Pinto-Bonilla3- 1Institute of Neurosciences, University of Granada, Granada, Spain
- 2Department of Anesthesia, Resuscitation, and Pain Treatment Service, Hospital Puerta del Mar, Cadiz, Spain
- 3Department of Embryology and Human Anatomy, School of Medicine, University of Valencia, Valencia, Spain
- 4School of Nursing, Catholic University of Murcia (UCAM), Murcia, Spain
The use of medical ozone in the treatment of chronic pain is progressively expanding in Spain and today it is used both in public and private medical centers. However, there is a great lack of knowledge about this technology not only in primary care but also in medical specialties. Although its biochemical bases are well determined and there are various systematic reviews and meta-analyses in the literature that justify its use in pain medicine, some professionals still are prejudiced against it. The evidence level of using medical ozone according SIGN (Scotish Intercollegiate Guideline Network) criteria is similar or superior to most of the techniques used in a Pain Unit. In this paper, we have done a review on ozone therapy in pain medicine, compiling the evidence published about it.
Introduction
Ozone therapy is the use of medical ozone as a therapeutic substance in pathologies with chronic hypoxia, inflammation, and redox imbalance in which ozone has proven to be effective (Baeza et al., 2015). Medical ozone is a mixture of oxygen and ozone obtained from medical oxygen by using a medical device – a medical ozone generator approved by a Notified Body according to the European Directive 93/42 and national regulations (Spanish RD 1591/2009). Medical ozone generators for parenteral use are classified in heading IIB of the classification of medical devices in EU regulations. Ozone therapy in medicine is a growing reality, and there are more and more professionals using medical ozone as a therapeutic tool for different diseases related to chronic oxidative stress and inflammation, including chronic pain.
In addition to health professional associations (such as the Spanish Ozone Therapy Association—SEOT or the World Federation of Ozone Therapy—WFOT) that try to unify criteria and develop protocols of treatment, as well as training health professionals in the use of this substance, the Catholic University of Murcia has taken the initiative by creating a chair of Ozone Therapy and Chronic Pain to better promote training and researching inside the Spanish universities network.
In Portugal and Greece, ozone therapy has a specific regulation and is used in public and private centers. In the rest of the European Union, it is used thanks to the legal recognition of medical ozone generators. In 2011, the Spanish Ministry of Health included the ozone therapy in the portfolio of services of the pain units (Palanca-Sánchez et al., 2011), so it is necessary that doctors who are experts in pain management know the rationale of medical ozone therapy and how it works, both locally and systemically.
Ozone is a molecule composed of three oxygen atoms (O3) instead of the two oxygen atoms found in the oxygen molecule (O2). Ozone has a half-life of 40 min at 20°C (Baeza et al., 2015); for this reason, it cannot be stored and must be produced “in situ” for each application.
Medical ozone applications date back to the beginning of the last century. The papers compiled in this publication have been published in the last 25 years and the oldest one have been included for historic reasons. Dr. Kellogg, in his book on diphtheria (1881) already mentioned ozone as a disinfectant, and in 1898 Drs Thauerkauf and Luth founded in Berlin the “Institute for oxygen therapy,” carrying out the first trials with animals. In 1911, the book “A Working Manual of High-Frequency Currents”, published by Dr. Noble Eberhart, head of the department of physiological therapeutics at Loyola University, described the use of medical ozone in the treatment of diseases such as tuberculosis, anemia, asthma, bronchitis, hay fever, diabetes, etc. (Pressman, 2021). But despite the successes achieved at the beginning of the last century, the ozone generating machines lacked precision and were quite fragile as they used a lot of glass tubes.
When applying this therapy, we are really inducing a controlled and harmless “micro-oxidation” that will produce a modulation of the cellular antioxidant system and the inflammation system. Ozone reacts with interstitial fluids producing hydrogen peroxide (H2O2), aldehydes, and lipid oxidation products (LOPs). These substances induce activation of the nuclear factor erythroid 2-related factor 2 (NRF2) pathway that will induce an increase in antioxidant systems (ARE), such as superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), glutathione peroxidase (GSH-Px), glutathione s-tranferase (GSTr), hem-oxygenase-1 (HO-1), reduced nicotinamide adenine dinucleotide phosphate (NADPH), NADPH quinone oxidoreductase 1 (NQO1) and heat shock protein-70 (HSP70; Baeza et al., 2015). This NRF2 activation (Figure 1) induces a decrease in the nuclear factor kappa beta (NFKβ) pathway activity, inducing an anti-inflammatory effect [decrease of interleukynes 1,2,6,7 and tumor necrosis factor alpha (TNFα) and increase of interlukynes 4, 10, 13 and transforming growing factor beta (TGFβ)] In the injected tissues, medical ozone inactivates proteolytic enzymes through the inhibition of the NFKβ pathway. At the same time, there is a proliferation of fibroblasts and chondrocytes, favoring cartilaginous regeneration (Fernández-Cuadros et al., 2020).
Figure 1. The chemical reaction between ozone and PUFA (poli-unsaturated fatty acids) in the insterstitial water (or plasma) produce several ROS, mainly H2O2, and several LOPs, mainly 4-HNE (4-hydroxynonenal). Almost all H2O2 is kidnaped by erythrocytes (not reflected in this figure) if present. In nucleated cells, LOPs activates the NRF2 pathway, inducing the production of ARE (antioxidant response elements) and blocking the NFKB pathway. A small amount of H2O2 stimulates the NFKB pahtway, usually balanced with the NRF2 blocking action, producing a inmmunomodulation.
Several authors have published preclinical studies on the effects of medical ozone on living organisms, being able to demonstrate beneficial effects on the ability to modulate the redox balance, the cellular inflammation status, and the adaptation to ischemia/reperfusion processes (Barber et al., 1998; Peralta et al., 2000; Ajamieh et al., 2003, 2004, 2005).
From a clinical point of view, ozone therapy presents multiple medical-surgical applications, all of them related to the germicidal capacity of ozone, chronic ischemic and inflammation processes, and imbalance of the cellular redox status. Several manuals collect the experience and scientific work carried out to date by different research groups, mainly Italians, Germans, Russians, and Cubans (Bocci, 2002; Menéndez et al., 2008).
The forms of application of medical ozone are basically three: topical, infiltrative, and systemic (Baeza et al., 2015). Topical applications take advantage of the germicidal power of ozone and its positive effect on the healing processes; it is usually applied directly, with the use of zip-lock bags, or by using ozonated water or ozonated oils. Infiltrated ozone at concentrations between 4 and 30 μg/ml is useful for treating musculoskeletal diseases such as arthritis, tendonitis, myositis, fasciitis, neuritis, or myofascial pain. Systemic ozone therapy consists of the administration of the mixture of gasses mainly through two routes: the indirect intravenous way (also known as autohemotherapy) and the rectal insufflation. Indirect intravenous administration consists of extracting a determined blood quantity that, within a closed circuit, is put into contact with the gas, which will dissolve and react in a few seconds, and immediately reinfused. Certified (EU marked) medical devices should be used for this procedure. Rectal insufflation consists of administering a gas enema with a probe into the rectum, where it reacts with rectal mucus and generates peroxides. These are absorbed by the mucosa, reaching the hemorrhoidal plexus and the general venous blood circulation system like any other rectal treatment. The probes must be made of silicone or other ozone-resistant plastic (OzoneSolution, 2021).
Infiltrations With Medical Ozone (O2/O3)
Generalities
The use of O2/O3 infiltrations to treat musculoskeletal pathology is increasingly widespreading. Verga (1989) was the first to describe ozone intramuscular applications at the paravertebral level and trigger points in patients with chronic low back pain. Later, in the 90s, this procedure was also used to treat acute and chronic polyarthritis (hip, knee, sacroiliac joint, and interphalangeal), tendinitis, epicondylitis, carpal tunnel syndrome, and myofascial pain (Ajamieh et al., 2005).
Despite its frequent use, the level of evidence in many of the mentioned indications, but for the treatment of lumbar disk herniation and knee osteoarthritis, is low, possibly because it has been mainly used for years in private practice where randomized clinical trials are difficult to carry out. Carmona (2005) published in 2005 a systematic review on the efficacy of ozone therapy in rheumatic diseases, concluding that there were no quality clinical trials, that most of the works were published in low-impact journals, and that the methodology between the different studies is highly variable. However, this situation is changing, as more countries are using medical ozone in public centers and universities.
Therapeutic Properties and Mechanisms of Action of Injected Ozone
When we infiltrate the oxygen/ozone mixture, we are infiltrating a highly oxidizing gas, with a good tissue diffusion capacity. Apart from the general biochemical effect described in the Introduction section, several authors have described the anti-inflammatory, analgesic, and anti-edema properties of injected medical ozone, and propose that the oxidation of the algogenic receptors would inhibit the pain signal and it would activate the antinociceptive system (Re et al., 2010). This fact has been checked in one preclinical study from Fuccio et al. (2009) by inducing sciatic damage in mice, He confirmed the corticofrontal activation of genes of caspase 1, 8, and 12 (pro-inflammatory, pro-apoptotic, and responsible for allodynia) caused by the injury; this expression was normalized with a single peripheral injection of O2/O3 around the damaged area, which also reduced mechanical allodynia.
These properties would favor a muscle relaxant effect, as well as improved mobility of the treated area that can be observed clinically (Siemsen, 1995). This fact is very important in muscle recovery with O2/O3 injections. Balkanyi (1989) has described the utility of ozone therapy in the treatment of painful muscle hypertonia, highlighting the tremendous muscle relaxant effect that is produced.
Regarding the nucleus pulposus of the intervertebral disk, several authors have described that ROS will react with amino acids and carbohydrates of proteoglycans and collagen I and II that make up the matrix, giving a lead to a process of “mummification” which would shrink the disk, reducing the compression (Hawkins and Davies, 1996; Bocci et al., 2001; Leonardi et al., 2001). Iliakis and his group studied the histological changes of the nucleus pulposus matrix after treatment with an ozone intradiscal injection at a concentration of 27 μg/ml in rabbits and humans (resected disk specimens using microdiscectomy after the failure of the ozone treatment). Five weeks after the injection there were no signs of perilesional chondrocytic hyperplasia or inflammatory infiltrates typically observed in herniated disks biopsies; there was a fibrous tissue of less volume (“disk mummified”), which supposes a decrease in compression on the nerve root, a decrease in venous ecstasy, an improvement in local circulation, greater oxygenation and less pain, given the great sensitivity to hypoxia of nerve roots (Iliakis et al., 2001). Similar findings in pigs at different ozone concentrations were reported by Muto (2004).
Dosage
Regarding dosage, standardized protocols are lacking. Most authors relate the amount of the gas mixture to the extension of the injury or to the size of the joint cavity to be infiltrated. Generally, the amounts of gas range between 5 and 15 ml, and ozone concentrations range from 4 to 30 μg/ml. The number of infiltration sessions usually ranges from 3 to 10 (usually one or two per week) depending on the specific evolution of each case. About intradiscal injection, 2 ml for cervical and 5 for ml is the most used amount. If a patient does not respond to treatment after two or three interventions (once every 2 weeks) it is considered a failure. Torres et al. (2009) in a 2009 publication, after having used different concentrations with the same clinical protocol, observed more improvements when intradiscal O2/O3 is infiltrated at 50 μg/ml compared to lower concentrations (25 and 30 μg/ml). Nevertheless, we recommend not reaching 50 μg/ml due to the risk of iatrogenic injuries on the ring that have been detected experimentally in pigs (Muto, 2004).
This lack of standardization in the treatment protocols makes difficult to compare results when performing a systematic review, not allowing to get high quality conclusions or recommendations.
Ozone Therapy in Knee Pathology
One of the historic references was done in 1989 by Riva (1989), that registered 156 patients with knee joint pathology (post-traumatic arthritis, knee osteoathritis with mild deformity, and knee osteoathritis with severe deformity) obtaining good results that were especially positive when there were no severe bone deformities. The treatment consisted of intra-articular and periarticular infiltrations of 10 ml of medical ozone at a concentration of 20 μg/ml.
Later, In Cuba, a prospective study was carried out in 1997 to evaluate the efficacy and safety of medical ozone injections in 126 patients with knee osteoarthritis; usually, three or four injections were needed to obtain positive results, and only 14 patients received more than five sessions. 71.4% of the patients had a good result, in 10.3% the result was fair, and in 18.3% the result was bad. The main complication was pain during infiltration. It was highlighted the economic savings due to the low cost of the infiltrations and the lesser need for anti-inflammatory drugs (Escarpanter et al., 1997). Several authors have also published their experience in case series (Delgado and Quesada, 2005; Huanqui et al., 2006) and even proposed a treatment guide for based on their personal experience (Gheza and Bissolotti, 2003).
Moretti et al. (2004a) worked on the early knee osteoarthritis, comparing intraarticular injected O2/O3 with intraarticular hyaluronic acid, concluding that although there were no statistically significant differences in efficacy, ozone could be more indicated in the early stages of this disease, where inflammation predominates. In the same line, Giombini et al. (2016) published a randomized control trial comparing three kinds of injections: medical ozone, hyaluronic acid, and the combination. This last group showed the best outcomes and the hyaluronic acid group was more effective than ozone but without statistically significant differences. A systematic review and meta-analysis from Li et al. (2018) comparing medical ozone and hyaluronic acid had similar results, checking that hyaluronic acid was better than ozone but both improved the clinical status of the patients and had no significant side effects. A publication from Lopes de Jesus et al. (2017) demonstrated through a multicenter randomized, double-blind clinical trial the efficacy of intra-articular ozone injections versus placebo in knee osteoarthritis. In 2018 (Anzolin and Bertol, 2018; Costa et al., 2018; Raeissadat et al., 2018), 2019 (Arias-Vázquez et al., 2019; Noori-Zadeh et al., 2019) and 2020 (Sconza et al., 2020), six systematic reviews and meta-analyses were published in different journals supporting the use of ozone in knee osteoarthritis with a high level of evidence (GRADE 1+; Table 1).
Table 1. Systematic reviews and meta-analysis on medical ozone in knee osteoarthritis (Anzolin and Bertol, 2018; Costa et al., 2018; Raeissadat et al., 2018; Arias-Vázquez et al., 2019; Noori-Zadeh et al., 2019; Sconza et al., 2020).
These studies do not compare the results according to the radiological status of the knee, and we think this is basic fact, because hyaluronic acid is not indicated for moderate or severe knee osteoarthritis. Further studies in this line are needed to clarify the indications for medical ozone. Cost-efficacy studies are also needed as medical ozone is far cheaper than hyaluronic acid.
Other inflammatory knee pathologies have also been studied. Peritendinosus injected ozone has been used with success in refractory knee tendinopathies (Gjonovich et al., 2003). They improved 36 athletes with “jumper’s knee” who had not improved after conventional treatments.
Patellofemoral chondromalacia is a painful pathology whose treatment is mainly surgical, after which there is often aftermath. Manzi and Raimondi (2002) treated 60 patients with injected O2/O3 that had persistent pain after conventional surgical treatment, obtaining a higher and faster resolution of the pain in the treatment group compared to the control group.
Ozone Therapy in Shoulder Pathology
Gjonovich et al. (2002) published a prospective controlled study of patients suffering from subacromial tendinopathy treated with injected ozone versus mesotherapy; the ozone group showed superior clinical results. Ikonomidis et al. (2002) demonstrated in a double-blind clinical trial the greater efficacy of injected O2/O3 versus steroid injections and physiotherapy also in subacromial tendinopathy.
Oxygen-ozone therapy has also been used successfully in combination with shock waves, to treat calcifying tendinitis of the shoulder (Trenti and Gheza, 2002). Brina and Villani (2004) have published the utility of ultrasound-guided O2/O3 infiltrations in patients with non-surgical lesions of the rotator cuff. Medical ozone can increase the efficacy of other substances, as it was shown in paper of Moretti (2011) with hyaluronic acid and in paper of Gurger et al. (2021) with platelet-rich plasma (PRP); this last paper verifies the collaborative effect of ozone and PRP from a histological point of view.
Ozone Therapy in Spinal Pathology
Undoubtedly, the largest number of published works focuses on the use of ozone therapy for the treatment of herniated disks, both cervical and lumbar.
The treatment of cervical herniated disks is generally more conservative than that of the lumbar, perhaps due to the higher index of serious complications from your surgery (Wang et al., 2007). In this context, the interest in intradiscal or paravertebral medical ozone injections has special relevance, and the analgesic, anti-inflammatory, and muscle relaxant effects of the ozone therapy in cervical pathology have been described (Albertini, 2002; Villa, 2002).
In 2004, Moretti et al. (2004b), conducted a clinical trial comparing the efficacy of ozone therapy versus mesotherapy in patients with neck pain, upper limb paresthesias (uni or bilateral), peripheral vertigo, and headache. One hundred and fifty two patients had hernias, protrusions, or spondylosis, 76 of which were treated with medical ozone infiltrations in paravertebral muscles, the trapezius, and the elevators of the scapula; the other 76 patients were treated with anti-inflammatory drugs and mesotherapy. The differences were statistically significant in favor of the group treated with oxygen-ozone with 78% of optimal or good results, compared to 56.25% in the group of mesotherapy.
Regarding cervical intradiscal injections, a work published by Xiao et al. (2006) also supports their efficacy. Eighty-six patients with cervical spondylosis treated with CT-guided infiltrations were retrospectively assessed. Thirty-seven suffered from myelopathy, 30 had radiculopathy and 19 had sympathetic symptoms. The indication for treatment was cervicalgia with neurological symptoms (brachial irradiation patterns, loss of tenderness, tingling, numbness, muscle weakness, or deficiency of deep tendon reflexes) and all should be refractory to conservative therapies for at least 12 weeks. Patients with cervical spinal stenosis, ossification of the posterior longitudinal ligament were excluded. The treatment with ozone therapy was excellent, good, or poor in 78, 16, and 6% of the cases, respectively, as recorded with the modified MacNab Scale. These results coincide with those published by Alexandre et al. (2005) in the same year.
In lumbar pathology the number of published works is large. The good results, along with the safety of the technique and the dreaded complications of the surgery, have made more and more authors consider ozone therapy, either paravertebral or intradiscal, the first choice in case of failure of conservative treatment.
Andreula et al. (2003) added intradiscal and periganglionic O2/O3 to the infiltration with local anesthetics and steroids; in the 6 months follow-up, by blind evaluators, a statistically significant improvement was observed with the combination of both treatments. No side effect was detected. Buric et al. (2003) did a prospective follow-up over 18 months of 104 patients with lumbosciatic pain due to disk protrusions treated with intradiscal and intraforaminal O2/O3 injections, finding improvements in pain and functional capacity in most of them. Disk volume measurements were made with MRI and it was observed that, at 5 months, 22% of the protrusions had not changed in volume, 41% had reduced the size and 37% had disappeared. The results indicated that the technique was effective in the treatment of protrusions, although the efficacy was not higher than that of the microdiscectomy, according to the authors’ experience (Buric, 2005). Also regarding disk protrusions, Qing et al. (2005), in a sample of 602 patients and 1,078 operated disks, concluded the suitability treatment with ozone therapy as the first choice after failure more conservative techniques. When comparing ozone therapy with other minimally invasive techniques, these authors considered that it was an effective, safe, and minimally stressful technique for the patient and easy to perform.
Bonetti et al. (2005), in a randomized clinical trial, compared the efficacy of intraforaminal infiltration of O2/O3 with periradicular infiltration of steroids. Three hundred and six patients with low back pain and neuropathic leg pain with and without disk disease (spondylosis, spondylolisthesis, and facet joint degeneration) were recruited and randomly divided into two groups (166 and 140). The main measuring instrument was the modified MacNab scale. Patients were evaluated in the short (1 week), medium (3 months), and long term (6 months). In short term, there were no statistically significant differences between the two treatment modalities (p = 0.4077). In long term, the differences in favor of ozone treatments were statistically significant, but only in the group of patients with disk disease (p = 0.0021); also in long term, it could be seen that ozone therapy treatments had statistically lower failure rate (8.6%) than treatments with steroids (21.4%).
Muto et al. (2008) performed CT-guided injections to 2,900 patients with lumbosciatic pain due to herniated disks (including relapses). The gas was injected intradiscal, peri-ganglionic, and periradicular. After a month the patients were reviewed, repeating the session in those cases in which the improvement was partial. At 6 and 12 months, there were improvements of 75–80% with simple disk herniation, 70% with multiple hernias, and 55% with relapses.
Equally positive results are obtained by Castro et al. (2009), in a prospective observational study in which they treated 41 patients with simultaneous intradiscal, epidural, and periradicular infiltrations. Patients with a herniated disk and free fragment and/or major neurological deficit were excluded. The evolution was very positive (according to the VAS and the Laitinen test) from the first to the last of the post-basal records (at 30 days and 6 months, respectively), and the degree of satisfaction was rated as good by 85.4% of the sample.
To clarify the long term results of this technique, Torres et al. (2009) designed a study in patients with sciatica due to herniated disc by applying three consecutive sessions of O2/O3 infiltrations once a week; the first two with an epidural [adding bupivacaine (5 ml to 0.25%) and triamcinolone (4 mg)] and paravertebral ozone and the third one, only with intradiscal ozone. The evolution of 91 patients was recorded for 24 months. A very significant improvement was achieved in 95.6% of the patients at the first-month follow-up visit, 87.7% at the first-year visit, and persisted at the end of the follow-up in 84.1% of the sample. They got one case of discitis and 11 cases of temporary headache and four cases of temporary low back pain. They found a significant reduction of the size of the hernia in 79% of the patients at 24 months MRI.
Although most of the works published refer to intradiscal injections, paravertebral injections are safer, more simple, and the most used in clinical practice, although their efficacy was under discussion. In 2006, a randomized clinical trial was published (Zambello et al., 2006) comparing the efficacy of muscular paravertebral infiltration of O2/O3 with that of epidural steroids in patients refractory to conventional treatment (oral steroids and muscle relaxants). One hundred and seventy one patients were treated with epidural steroids and 180 underwent paravertebral infiltrations of medical ozone. At the 3 weeks follow-up, the improvement was statistically significant in favor of patients treated with ozone therapy (total or almost total remission of pain in 88.2%, compared to 59% in the steroids group), and at 6 months the evolution was excellent or good in 77.1% of patients treated with ozone therapy, compared to 47.3% of patients treated with steroids.
A double-blind randomized clinical trial was conducted (Paoloni et al., 2009) to better assess the efficacy of paravertebral ozone infiltrations in the treatment of acute low back pain due to herniated disk. Sixty patients were recruited and randomized into two groups; one was treated with real infiltrations and in the other group these were simulated. Follow-up was done 15, 30, 90, and 180 days after ending the treatment. Patients treated with true ozone injections significantly improved the pain and functional limitation (p < 0.05), requiring less analgesic medication.
In 2010, a meta-analysis was published (Steppan et al., 2010) on the efficacy and safety of ozone therapy for the treatment of herniated disks. Twelve studies were included with a total sample of 8,000 patients; the mean improvements recorded were similar to those reported for discectomy: 3.9 points out of 10 on the visual analog pain scale, 25.7 points in functional capacity according to the Oswestry Disability Index and a 79.7% improvement in the records of the modified MacNab scale. The percentage of complications was 0.064%, so the treatment was considered safe and effective. Two years later, Magalhaes et al. (2012) published a systematic review and meta-analysis compiling eight observational studies and four randomized clinical trials. They concluded that the intradiscal injection to treat lumbar disk herniation has a recommendation level of 1C and that the paravertebral treatment has a recommendation level 1B according to the criteria of the US Preventive Services Task Force; this means that the recommendation is strong (maximum level), although with certain reservations for intradiscal injection due to the diversity of existing protocols.
About 80% of the population in Western countries will experience at least one episode of low back pain in your lifetime, and 55% of these will have an associated radicular pain (Long, 1991). Failed back surgery syndrome ranges between 15% and 20%, which leads to propose more conservative and less invasive treatments, such as ozone therapy, whose effectiveness seems to oscillate between 65 and 80% suggesting that a small change in disk volume can produce a large clinical change (Gangi et al., 1998). Complications of open surgery must also be taken into account, such as fibrosis, epidural and perineural tears, nerve adhesions, limitations of biomechanics due to fibrosis, and muscle paravertebral spasms and associated myofascial syndromes (Manchikanti et al., 2007). In this context, infiltrations with O2/O3, both at the paravertebral level and trigger points of related musculature and percutaneous intradiscal injection with ozone, are techniques on the rise due to their efficacy, ease of execution, low cost, and very few important side effects.
Andreula et al. (2003), when comparing ozone intradiscal injection with enzymatic nucleolysis, conclude that, with similar clinical results, treatment with ozone therapy would be the first choice due to its advantages like the ones that follow:
•There is no possibility of allergic reactions or anaphylactic
•Possibility of repeating the treatment as many times as it is considered
•Theoretical lower risk of infections, due to the germicides properties of ozone
•Possibility of using a thinner needle due to ozone fluidity and, therefore, a so much less traumatic injection
•Less post-infiltration discomfort (2, 3 days vs. 1 or 2 weeks).
To these advantages would be added those described over corticosteroids due to the absence of ozone adverse effects. In this regard, Fernández et al. (1998), in their review on the use of corticosteroids draw attention to the following points:
•Infectious arthritis
•Progressive joint deterioration
•Soft-tissue atrophy and hypopigmentation
•Tendon rupture
•Reactive synovitis due to glucocorticoid microcrystals
•Systemic adverse effects.
Some recent publications remark that the ozone administration does not close the path to surgery in case of failure (Bocci et al., 2015; Muto et al., 2016).
Finally, it is worth mentioning that the efficacy of ozone therapy in the treatment of failed back surgery syndrome, highly prevalent among spine-operated patients, and usually worsens with new surgeries. In these patients, we observe fibrosis due to epidural and perineural scars, paravertebral spasms, and neural adhesions, whose chronic inflammatory stimulus would lead to neuroplastic phenomena with central and peripheral sensitization. Theoretically, the fibrinolytic, anti-inflammatory and antioxidant properties of the infiltrated O2/O3 would make it ideal for the treatment of these processes. The team from the National Medical Center 20 de Noviembre, in Mexico City, has published two papers treating 30 patients in each work. On both studies applied a first epidural injection together paravertebral infiltration followed by three weekly sessions of paravertebral infiltrations; doses of 20 ml at 30 μg/ml in the first paper and the same amount at 50 μg/ml in the second one, but the treatments could not improve patients’ pain (Grijalva et al., 2012; Hernández et al., 2012). A promising alternative would be the combination of repeated paravertebral injections combined with epidural ones. Padilla del Rey et al. (2015) reported very significant improvement (VAS of 10 a 3) in a patient with refractory post-laminectomy pain who received three epidural infiltrations with ozone (10 ml at 20 μg/ml concentration) in three consecutive weeks and six paravertebral infiltrations, twice a week at the same time (10 ml at 10–30 μg/ml progressive concentration). Anyway, given the scale of the problem, more studies are needed.
Infiltrative Ozone Therapy in Rheumatoid Arthritis
A preclinical study carried out in Nanfang Hospital compared the effects of medical ozone infiltrations at different concentrations compared to oxygen; the authors showed that intra-articular ozone injected at a concentration of 40 μg/ml is capable of inhibiting synovitis in rats with rheumatoid arthritis (Chen et al., 2013). Some doctors use ozone therapy empirically in patients with rheumatic diseases using joint infiltrations for years, supposedly with very positive results, but there are no major works published in this regard.
Other Applications of Infiltrated Oxygen/Ozone
Other indications published in case series studies are tendinopathies and neural entrapment syndromes, lateral epicondylitis, rhizoarthrosis, spondylolisthesis, spondylolysis, plantar fasciitis, septic spondylodiscitis, D′Quervain’s tenosynovitis, metatarsalgia due to postsurgical fibrosis after resection of Morton’s neuroma or temporomandibular joint pathology (Bonetti et al., 2002, 2011; Gheza, 2002; Gheza et al., 2002; Zanardi and Zorandi, 2002; Bonetti, 2003; Gaffuri et al., 2003; Ikonomides et al., 2003; Moretti et al., 2005; Alvarado, 2006; Babaei-Ghazani et al., 2019).
Systemic Ozone Therapy in Pain Medicine
As mentioned, ozone therapy would be indicated as an adjuvant treatment of diseases related to disturbance of cellular redox balance or tissue oxygenation. From this point of view, systemic ozone therapy would help patients with pain chronic, as recent preclinical studies have demonstrated the role of ROS in hyperalgesia, via activation of the N-methyl-D-aspartate (NMDA) receptors. Gao et al. (2007), in a preclinical model of pain, both neuropathic and inflammatory, could demonstrate that ROS were increased at the dorsal horn in these patients, and that systemic administration of a neutralizing agent of ROS reduced the hyperalgesia by blocking phosphorylation from NMDAs. Later, the same research group (inducing hyperalgesia by capsaicin in rats) was able to demonstrate the role of the superoxide anion as responsible for abnormal pain signal processing in the dorsal horn, suggesting the therapeutic role of mitochondrial SOD-2 in these types of pain (Schwartz et al., 2009).
But certainly, the levels of scientific evidence in the treatment with systemic ozone therapy for chronic pain are practically non-existent. In this regard, a study by Clavo et al. (2013), on chronic headache refractory to triptans, found that systemic ozone improved pain and frequency of crises. Also, Fernández et al. (2016) published a work in which the use of systemic ozone therapy improved efficacy and decreased the side effects of methotrexate in patients with rheumatoid arthritis. Theoretically, the beneficial effect on immunosuppressed patients would make it useful, both in the treatment of herpes zoster infection and postherpetic neuralgia (Hu et al., 2018). In this field, several experts have tried ozone treatments for years, apparently with positive results. Ozone therapy is generally used as an adjunct to conventional treatments, either systemic or local (infiltrations or applications of oils and ozonated water; Mattassi et al., 1985; Delgado et al., 1989; Konrad, 2001). These studies have a low evidence level but are useful to encourage the development of better-designed works.
Fibromyalgia seems to be a “stress disease” in which underlies an alteration of the cellular redox balance, consequence of an increase in the production of free radicals, a deficiency of organic antioxidant capacity, or both simultaneously. Biochemical findings support this fact and systemic ozone therapy has been proposed (Borrelli and Bocci, 2002; Hidalgo, 2012). Hidalgo et al. (2005) treated 21 patients with fibromyalgia refractory to a multidisciplinary treatment with 10 sessions of autohemotherapy, finding very good tolerability and improvement in pain and fatigue, as well as a significant decrease in the use of pain medication. This same research group (Hidalgo-Tallón et al., 2013) treated 36 patients with fibromyalgia with one daily dose of rectal ozone (200 ml of gas at 40 μg/ml) during 24 sessions, reporting significant improvements in the Fibromyalgia Impact Questionnaire, the state of mind, and the physical component of the quality of life using SF-12 scale. The treatment was very well tolerated, with transient meteorism as the most relevant adverse effect.
Systemic ozone has also been tested together with infiltrations in patients with rheumatoid arthritis. A Calunga et al. (2007) research group, published a study about lumbar disk herniation comparing paravertebral infiltrations isolated or combined with rectal ozone and checked that the combination improved all clinical parameters. In 2010, they compared (Méndez-Pérez et al., 2010) isolated O2/O3 intra-articular infiltrations (3 ml at 10 μg/ml) with the infiltrations plus rectal ozone in patients with rheumatoid arthritis of the temporomandibular joint; improvements, both in pain and in function and state of the joint capsule were statistically significant in favor of the combination therapy. In this regard, systemic ozone therapy seems to decrease in these patients interleukin 1 beta levels, directly related to disease activity, while intraarticular ozone injections would decrease intraarticular interleukin 8 levels, justifying lower granulocyte count and clinical improvement (Eastgate et al., 1988; Menéndez et al., 1989; Fahmy, 1993, 1995).
Safety and Contraindications of Ozone Therapy
All authors agree on the high safety of treatments with ozone therapy, especially modern medical ozone generators with great precision.
Jacobs (1982) published that the incidence of effects adverse effects of systemic ozone therapy was only 0.0007%, mainly nausea, headache, and fatigue. In Cuba, with 25 years of experience, having at least one ozone therapy unit per province of the country, only slight adverse effects have been recorded (Bocci, 2002).
The experience of Italian experts is similar, although Dr. Bocci (Ajamieh et al., 2005) describes at least six deaths from gas applications in a direct intravenous way, a practice not recommended by scientific associations (Baeza et al., 2015).
Eventually, the most serious common adverse effect would be a vagal reaction, generally associated with pain during infiltration. It is necessary to note that the injection must be done slowly, especially if a large gas volume at a high concentration is used (Zambello et al., 2004).
However, some other complications have been reported in the literature, most of them due to malpractice or without a causal relationship between the ozone administration and the adverse event (Marchetti and La Monaca, 2000; Corea et al., 2004; Lo Giudice et al., 2004; Ginanneschi et al., 2006; Gazzeri et al., 2007; Bo et al., 2009; Seyman et al., 2012; Vilas-Rolan et al., 2012; Fort et al., 2014; Menéndez et al., 2014; Mustafa et al., 2015; Vanni et al., 2015; Cano et al., 2016; Salvatore et al., 2016; Balan et al., 2017; Hüseyin et al., 2017; Wen-Juan et al., 2017; Beyaz et al., 2018; Yang et al., 2018; He et al., 2019). Most of them disappeared in a few days not needing specific medical treatment.
An absolute contraindication is severe glucose-6 deficiency phosphate dehydrogenase (favism), as this enzyme is necessary for supply hydrogen ions to the glutathione system, responsible for buffering the oxidation that lipoperoxides will produce in red blood cells (Viebahn, 2007).
As relative contraindications to systemic ozone therapy would be uncontrolled hyperthyroidism, thrombocytopenia, severe cardiovascular instability, and seizure states. It is also not advisable to use systemic ozone therapy in pregnant patients (Bocci, 2002) as it has not been deeply tested. Infiltrations should be avoided following the general criteria described in the literature (Sánchez et al., 2006).
Undoubtedly, ozone therapy should be practiced by a well-trained doctor and, in patients with a poor general condition, a diagnosis of the pro-oxidant/antioxidant status of the patient would be advisable.
Conclusion
For knee osteoarthritis and lumbar disk herniation, evidence on safety and efficacy from systematic reviews and meta-analysis, according the quality of the evidences proposed by the Scottish Intercollegiate Guidelines Network (SIGN), including GRADE criteria, are high (1+ and 2+ studies) and allow a recommendation level B, the same observed in most of the techniques used presently in pain units (SIGN, 2019).
However, for the rest of potential indications, the evidence level is low and ozone must be used only when other conventional treatments have failed or in a compassionate way.
Lack of standardization in treatment protocols is the Achilles’ heel of this technique, probably because of his great tolerablity that encourage doctors to explore different dosages without comparing efficacy between them. This is the main criticism in systematic reviews’ conclusions.
More RCT are needed to increase our knowledge on the indications of medical ozone, but safety profile is good enough so as to develop them. Fortunately, research interest on ozone therapy is growing, as we can check by simply doing a basic research in PubMed and watching the evolution of the number of publications in the past 20 years.
Author Contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work, and approved it for publication.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Ajamieh, H. H., Berlanga, J., Merino, N., Sánchez, G. M., Carmona, A. M., Cepero, S. M., et al. (2005). Role of protein synthesis in the protection conferred by ozone – oxidative – preconditioning in hepatic ischemia/reperfusion. Transpl. Int. 18, 604–612. doi: 10.1111/j.1432-2277.2005.00101.x
Ajamieh, H. H., Menéndez, S., Martínez-Sánchez, G., Candelario-Jalil, E., Re, L., Giuliani, A., et al. (2004). Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischemia – reperfusion. Liver Int. 24, 55–62. doi: 10.1111/j.1478-3231.2004.00885.x
Ajamieh, H. H., Menéndez, S., Merino, N., Martinez-Sanchez, G., Re, L., and León, O. S. (2003). Ischemic and ozone oxidative preconditioning in the protection against hepatic ischemic-reperfusion injury. Ozone Sci. Eng. 25, 241–250. doi: 10.1080/01919510390481568
Albertini, F. (2002). Ozone administration in the treatment of herniated cervical disc: case report. Riv. Ital. Ossigeno-Ozone Ther. 1, 203–206.
Alexandre, A., Coro, L., Azuelos, A., Buric, J., Salgado, H., Murga, M., et al. (2005). “Intradiscal injection of oxygen-ozone gas mixture for the treatment of cervical disc herniations,” in Advanced Peripheral Nerve Surgery and Minimal Invasive Spinal Surgery. ed. A. Alexandre. Vienna: Springer.
Alvarado, R. (2006). Ozonetherapy to resolve disc space infection spondylodiscitis. Riv. Ital. Ossigeno-Ozone Ther. 5, 117–121.
Andreula, C. F., Simonetti, L., De Santis, F., Agati, R., Ricci, R., and Leonardi, M. (2003). Minimally invasive oxygen-ozone therapy for lumbar disk herniation. Am. J. Neuroradiol. 24, 996–1000.
Anzolin, A. P., and Bertol, C. D. (2018). Ozonioterapia como terapêutica integrativa no tratamento da osteoartrose: uma revisão sistemática. Br. J. Pain 1, 171–175. doi: 10.5935/2595-0118.20180033
Arias-Vázquez, P. I., Tovilla-Zárate, C. A., Bermudez-Ocaña, D. Y., Legorreta-Ramírez, B. G., and López-Narváez, M. L. (2019). Eficacia de las infiltraciones con ozono en el tratamiento de la osteoartritis de rodilla vs. otros tratamientos intervencionistas: revisión sistemática de ensayos clínicos. Rehabilitación. 53, 43–55. doi: 10.1016/j.rh.2018.11.001
Babaei-Ghazani, A., Karimi, N., Forogh, B., Madani, S. P., Ebadi, S., Fadavi, H. R., et al. (2019). Comparison of ultrasound-guided local ozone (O2-O3) injection vs corticosteroid injection in the treatment of chronic plantar fasciitis: a randomized clinical trial. Pain Med. 20, 314–322. doi: 10.1093/pm/pny066
Baeza, J., Cabo, J. R., Gómez, M., Menendez, S., and Re, L.. (2015). WFOTs Review on Evidence Based Ozone Therapy. Brescia: WFOT.
Balan, C., Schiopu, M., Balasa, D., and Balan, C. (2017). Ozone therapy – a rare and avoidable source of infectious pathology of the spine. Rom Neurosurg. 31:46. doi: 10.1515/romneu-2017-0046
Balkanyi, A. (1989). “The interaction between ozone therapy and oxygen radicals and their importance in practice.” in Proceedings of the Ninth Ozone World Congress; June 3–9, 1989; New York; 22–27.
Barber, E., Menéndez, S., Barber, M. O., Merino, N., and Calunga, J. L. (1998). Functional and morphological renal study in kidneys of rats pretreated with ozone and subjected to warm ischemia. CENIC Biol. Sci. 29, 178–181.
Beyaz, S. G., Altaş, C., and Sayhan, H. (2018). Cardiopulmonary arrest and pneumoencephaly developing after epidural oxygen-ozone mixture therapy. Anesth. Essays Res. 12, 285–287. doi: 10.4103/aer.AER_142_17
Bo, W., Longyi, C., Jian, T., Guangfu, H., Hailong, F., Weidong, L., et al. (2009). A pyogenic discitis at C3–C4 with associated ventral epidural abscess involving C1–C4 after intradiscal oxygen-ozone chemonucleolysis. Case Rep. 34, E298–E304. doi: 10.1097/BRS.0b013e318195a87e
Bocci, V. (2002). Oxygen-Ozone Therapy. A Critical Evaluation. Dordrecht: Kluwer Academic Publishers.
Bocci, V., Borrelli, E., Zanardi, I., and Travagli, V. (2015). The usefulness of ozone treatment in spinal pain. Drug Des. Devel. Ther. 9:2677. doi: 10.2147/DDDT.S74518
Bocci, V., Pogni, R., Corradeschi, F., Busi, E., Cervelli, C., Bocchi, L., et al. (2001). Oxygen-ozone in orthopedics: EPR detection of hydroxyl free radicals in ozone-treated “nucleus pulposus” material. Riv. Neuroradiol. 14, 55–59. doi: 10.1177/197140090101400106
Bonetti, M. (2003). CT-guided oxygen-ozone infiltration into isthmic lysis points in the management of 1st negree spondylolisthesis and spondylolysis. Riv. Ital. Ossigeno-Ozone Ther. 2, 31–38.
Bonetti, M., Cotticelli, B., Richelmi, P., and Valdenassi, L. (2002). Rofecoxib e O2-O3 therapy vs O2-O3 therapy in the spondyloarthrosis treatment. Riv. Ital. Ossigeno-Ozone Ther. 1, 171–178.
Bonetti, M., Fontana, A., Cotticelli, B., Dalla Volta, G., Guindani, M., and Leonardi, M. (2005). Intraforaminal O2-O3 versus periradicular steroidal infiltrations in lower back pain: randomized controlled study. Am. J. Neuroradiol. 26, 996–1000.
Bonetti, M., Moretti, M., Guarino, G., and Bragaglio, G. (2011). Rhizoarthrosis: our experience with oxygen-ozone treatment. Riv. Ital. Ossigeno-Ozone Ther 10, 63–63.
Borrelli, E., and Bocci, V. (2002). A novel therapeutic option for chronic fatigue syndrome and fibromyalgia. Riv. Ital. Ossigeno-Ozone Ther. 1, 149–153.
Brina, L., and Villani, P. C. (2004). Treatment of rotator cuff lesions with echo-guided infiltration of an oxygen-ozone mixture. Riv. Ital. Ossigeno-Ozone Ther. 3, 139–147.
Buric, J. (2005). Ozone chemyonucleolysis vs microdiscectoy. Prospective controlled study with 18 months follow-up. Riv. Ital. Ossigeno-Ozone Ther. 4, 49–54.
Buric, J., Alexandre, A., Coro, L., and Azuelos, A. (2003). Intradiscal ozone treatment of non-contained disc Herniations. Riv. Ital. Ossigeno-Ozone Ther. 2, 153–160.
Calunga, J. L., Ramos, T. L., Castillo, P., Menéndez, S., Carballo, A., and Céspedes, J. (2007). Ozonoterapia combinada en el tratamiento del paciente portador de hernia discal lumbar: estudio preliminar. Rev Cubana Invest Bioméd [Internet]. 2007 Mar [cited 2021 Nov 30]; 26. Available in: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002007000100003&lng=esn
Cano, P. A., Vela, T., Cano, C., García, G., Vera, J. C., and Andrés-García, J. A. (2016). Cervical spondylodiscitis after oxygen–ozone therapy for treatment of a cervical disc herniation: a case report and review of the literature. HSSJ. 12, 278–283. doi: 10.1007/s11420-016-9500-1
Carmona, L. (2005). Systematic review: ozone therapy in diseases rheumatic. Clin. Rheumatol. 2, 119–123.
Castro, M., Cánovas, L., Martínez, J., Pastor, A., Segado, I., Rocha, F., et al. (2009). Percutaneous ozone dyscolysis: our experience. Rev. Soc. Esp Dolor. 16, 405–409. doi: 10.1016/S1134-8046(09)72821-6
Chen, H., Yu, B., Lu, C., and Lin, Q. (2013). The effect of intra-articular injection of different concentrations of ozone on the level of TNF-α, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis. Rheumatol. Int. 33, 1223–1227. doi: 10.1007/s00296-012-2529-7
Clavo, B., Santana-Rodriguez, N., Gutierrez, D., Lopez, J. C., Suarez, G., Lopez, L., et al. (2013). Long-term improvement in refractory headache following ozone therapy. J. Altern. Complement. Med. 19, 453–458. doi: 10.1089/acm.2012.0273
Corea, F., Amici, S., Murgia, N., and Tambasco, N. (2004). A case of vertebrobasilar stroke during oxygen-ozone therapy. J. Stroke Cerebrovasc. Dis. 13, 259–261. doi: 10.1016/j.jstrokecerebrovasdis.2004.08.004
Costa, T., Rodrigues-Manica, S., Lopes, C., Gomes, J., Marona, J., Falcão, S., et al. (2018). Ozone therapy in knee osteoarthritis: a systematic review. Acta Medica Port. 31, 576–580. doi: 10.20344/amp.10330
Delgado, E., and Quesada, J. V. (2005). Intra-articular ozone therapy in arthritic knee disease. Rev. Cuba. Ortop. Traumatol. 19, 23–28.
Delgado, J., Wong, R., Menéndez, S., and Gómez, M. (1989). Treatment with ozone from herpes zoster. Rev Cenic Biol. 20, 160–161.
Eastgate, J., Wood, N., Di Giovine, F., Symons, J., Grinlinton, F., and Duff, G. (1988). Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 332, 706–709. doi: 10.1016/S0140-6736(88)90185-7
Escarpanter, J. C., Valdés, O., Sánchez, R., López, Y., and López, C. (1997). Therapeutic results in osteoarthritis of the knee with ozone infiltrations. Rev. Cuba. Investig. Biomed. 16, 124–132.
Fahmy, Z. (1993). “Immunological effect of ozone (O2-O3) in rheumatic diseases.” in Proceedings of the Eleventh Ozone World Congress, Ozone in Medicine. (Stamford, Conn.: International Ozone Association); August 29 - September 3, 1993; San Francisco, CA, USA.
Fahmy, Z. (1995). “Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis with and without Ozone.” in Proceedings of the 12th Ozone World Congress (Stamford, Conn.: International Ozone Association); May 15-18, 1995; Lille, France.
Fernández, A. M., Povedano, J., Campos, S., and García-López, A. (1998). Clinical efficacy of steroid injections. Reumatol. Clin. 25, 361–370.
Fernández, O. S. L., Viebahn-Haensler, R., Cabreja, G. L., Espinosa, I. S., Matos, Y. H., Roche, L. D., et al. (2016). Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis. Eur. J. Pharmacol. 789, 313–318. doi: 10.1016/j.ejphar.2016.07.031
Fernández-Cuadros, M. E., Pérez-Moro, O., Albaladejo-Florin, M. J., and Álava-Rabasa, S. (2020). El ozono intrarticular modula la inflamación, mejora el dolor, la rigidez, la función y tiene un efecto anabólico sobre la artrosis de rodilla: estudio cuasiexperimental prospectivo tipo antes-después, 115 pacientes. Rev Soc Esp Dolor. 27, 78–88. doi: 10.20986/resed.2020.3775/2019
Fort, N. M., Aichmair, A., Miller, A. O., and Girardi, P. (2014). L5–S1 Achromobacter xylosoxidans infection. Spine 39, E413–E416. doi: 10.1097/BRS.0000000000000195
Fuccio, C., Luongo, C., Capodanno, P., Giordano, C., Scafuro, M. A., Siniscalco, D., et al. (2009). A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. Eur. J. Pharmacol. 603, 42–49. doi: 10.1016/j.ejphar.2008.11.060
Gaffuri, M., Garaffo, R., and Gheza, G. (2003). Oxygen-ozone therapy for lateral humeral epicondylitis: preliminary findings. Riv. It Ossigeno-Ozone Ther. 2, 169–172.
Gangi, A., Dietemann, J. L., Mortazavi, R., Pfleger, D., Kauff, C., and Roy, C. (1998). CT-guided interventional procedures for pain management in the lumbosacral spine. Radiographics 18, 621–633. doi: 10.1148/radiographics.18.3.9599387
Gao, X., Kim, H. K., Chung, J. M., and Chung, K. (2007). Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 131, 262–271. doi: 10.1016/j.pain.2007.01.011
Gazzeri, R., Galarza, M., Neroni, M., Esposito, S., and Alfieri, A. (2007). Fulminating septicemia secondary to oxygen-ozone therapy for lumbar disc herniation. Case Rep. 32, E121–E123. doi: 10.1097/01.brs.0000254125.85406.6e
Gheza, G. (2002). Metatarsalgia trattata with O2-O3 in peace with fibrosis post-chirurgical scarring of Morton’s neuroma asportazione. Riv. Ital. Ossigeno-Ozone Ther. 1, 109–111.
Gheza, G., and Bissolotti, L. (2003). Intra-articular oxygen-ozone injection for knee disease. Proposed guidelines. Riv. Ital. Ossigeno-Ozone Ther. 2, 63–66.
Gheza, G., Ipprio, L., and Bissolotti, L. (2002). Oxygen-ozone therapy in a diabetic patient with De Quervain’s tenosynovitis associated with joint arthrosis. Riv. Ital. Ossigeno-Ozone Ther. 1, 189–192.
Ginanneschi, F., Cervelli, C., Milani, P., and Rossi, A. (2006). Ventral and dorsal root injury after oxygen-ozone therapy for lumbar disk herniation. Surg. Neurol. 66, 619–620. doi: 10.1016/j.surneu.2006.01.025
Giombini, A., Menotti, F., Di Cesare, A., Giovannangeli, F., Rizzo, M., Moffa, S., et al. (2016). Comparison between intrarticular injection of hyaluronic acid, oxygen ozone, and the combination of both in the treatment of knee osteoarthrosis. J. Biol. Regul. Homeost. Agents 30, 621–625.
Gjonovich, A., Girotto, L., Sattin, G. F., Girotto, T., and Preciso, G. (2002). Oxygen-ozone therapy in shoulder pain. Riv. Ital. Ossigeno-Ozone Ther. 1, 37–40.
Gjonovich, A., Marchetto, R., Montemarà, E., and Girotto, T. (2003). Refractory tendinopathies of the knee: use of oxygen-ozone therapy. Riv. Ital. Ossigeno-Ozone Ther. 2, 187–192.
Grijalva, Y. M., Hernández, J. R., Tenopala, S., Canseco, C. P., and Torres, J. C. (2012). Application efficiency of epidural and paravertebral ozone at a concentration of 50 μg/ml in patients with chronic pain secondary to postlaminectomy syndrome. Rev. Soc. Esp Dolor. 19, 66–71.
Gurger, M., Once, G., Yilmaz, E., Demir, S., Calik, I., Say, Y., et al. (2021). The effect of the platelet-rich plasma and ozone therapy on tendon-to-bone healing in the rabbit rotator cuff repair model. J. Orthop. Surg. Res. 16:202. doi: 10.1186/s13018-021-02320-w
Hawkins, C. L., and Davies, M. J. (1996). Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. Free Radic. Biol. Med. 21, 275–290. doi: 10.1016/0891-5849(96)00042-1
He, R., Huang, Q., Yan, X., Liu, Y., Yang, J., and Chen, X. (2019). A case of paradoxical embolism causing anterior spinal cord syndrome and acute myocardial infarction following the Intradiscal oxygen-ozone therapy. Front. Neurol. 10:137. doi: 10.3389/fneur.2019.00137
Hernández, B. D., Hernández, J. R., Tenopala, S., Canseco, C. P., and Torres, J. C. (2012). Application efficiency epidural and paravertebral ozone at a concentration of 30 μg/ml for the management of chronic pain in patients with failed surgery syndrome back. Rev. Soc. Esp Dolor. 19, 3–10.
Hidalgo, F. J. (2012). Fibromyalgia: An oxidative stress disorder. Rev. Soc. Esp. Dolor. 19, 95–100.
Hidalgo, F. J., Calandre, E., Rico, F., Delgado, A., Entrena, J. M., and Menéndez, S.. (2005). “Interest of systemic ozone in the treatment of highly refractory fibromyalgia.” in IV Jornadas Nacionales de Oxígeno-ozonoterapia médica. Noviembre 4-5, 2005; Sevilla (Spain).
Hidalgo-Tallón, F. J., Menéndez-Cepero, S., Vilchez, J. S., Rodríguez-López, C. M., and Calandre, E. P. (2013). Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: an open-label pilot study. J. Altern. Complement. Med. 19, 238–242. doi: 10.1089/acm.2011.0739
Hu, B., Zheng, J., Liu, Q., Yang, Y., and Zhang, Y. (2018). The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia. J. Pain Res. 11, 1637–1643. doi: 10.2147/JPR.S154154
Huanqui, C., Cruz, M., Miranda, A., Poblete, P., and Mamani, R. (2006). Effectiveness and safety of intra-articular ozone in knee osteoarthritis refractory to treatment. UCSM 12, 21–26.
Hüseyin, T., Uğur, Ö., Hasan, K., and Nurettin, L. (2017). Severe headache following ozone therapy: Pneumocephalus. Agri 29, 132–136. doi: 10.5505/agri.2016.36024
Ikonomides, S. T., Iliakis, E. M., Eleftheriadou, A., Bratanis, D., and Thomaidis, R. (2003). Conservative treatment of acute or chronic tendonitis with oxygen-ozone mixture. Riv. Ital. Ossigeno-Ozone Ther. 2, 67–71.
Ikonomidis, S. T., Iliakis, E. M., and Charalambus, L. (2002). Nonoperative treatment of shoulder impingement syndrome with topical injections of medical oxygen-ozone mixture. A double blind clinical trial. Riv. Ital. Ossigeno-Ozone Ther. 1, 41–44.
Iliakis, E., Valadakis, V., Vynios, D. H., Tsiganos, C. P., and Agapitos, E. (2001). Rationalization of the activity of medical ozone on intervertebral disc a histological and biochemical study. Riv. Neuroradiol. 14, 23–30. doi: 10.1177/19714009010140S105
Jacobs, M. T. (1982). Untersuchung uber Zwischenfalle und typische komplikationen in der Ozon-sauerstoff-therapie. OzoNachrichten. 1, 1–5.
Konrad, H. (2001). “Ozone therapy for postherpetic neuralgia. A retrospective study of 55 cases.” in Proceedings of the 15th Ozone World congress, Medical Therapy Conference (Stamford, Conn.: International Ozone Association). September 11-15, 2011; London, UK.
Leonardi, M., Simonetti, L., and Barbara, C. (2001). Effetti dell’ozono sul nucleo polposo: reperti anatomo-pathologici its an operative case. Riv. Neuroradiol. 14, 57–59. doi: 10.1177/19714009010140S113
Li, Q., Qi, X., and Zhang, Z. (2018). Intra-articular oxygen-ozone versus hyaluronic acid in knee osteoarthritis: A meta-analysis of randomized controlled trials. Int. J. Surg. 58, 3–10. doi: 10.1016/j.ijsu.2018.08.007
Lo Giudice, G., Valdi, F., Maurizio, G., Prosdocimo, G., and de Belvis, V. (2004). Acute bilateral vitreo-retinal hemorrhages following oxygen-ozone therapy for lumbar disk herniation. Am. J. Ophth. 138, 175–177. doi: 10.1016/j.ajo.2004.02.059
Lopes de Jesus, C. C., Dos Santos, F. C., de Jesus, L. M. O. B., Monteiro, I., Sant’Ana, M. S. S. C., and Trevisani, V. F. M. (2017). Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: a randomized, double-blinded, placebo-controlled study. PLoS One 12:e0179185. doi: 10.1371/journal.pone.0179185
Magalhaes, F. N., Dotta, L., Sasse, A., Teixeira, M. J., and Fonoff, E. T. (2012). Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials. Pain Physician 15, E115–E129.
Manchikanti, L., Singh, V., Cash, K. A., Pampati, V., and Datta, S. (2007). Preliminary results of a randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: part 3 – post surgery syndrome. Pain Physician 11, 817–831.
Manzi, R., and Raimondi, D. (2002). The role of oxygen-ozone therapy in patellofemoral chondromalacia. Riv. Ital. Ossigeno-Ozone Ther. 1, 31–35.
Marchetti, D., and La Monaca, G. (2000). An unexpected death during oxygen-ozone therapy. Am. J. Forensic Med. Pathol. 21, 144–147. doi: 10.1097/00000433-200006000-00010
Mattassi, R., Bassi, P., D’Angelo, F., Franchina, A., and Sbrascini, S. (1985). “Ozone as therapy in herpes simplex and herpes zoster diseases,” in Medical Applications of Ozone. ed. J. LaRous (Norwalk: International Ozone Association), 134–137.
Méndez-Pérez, I., Cerro-Montesino, A. D., Cámbara-Peña, R., Martínez-Godíne, J., and Menéndez-Cepero, S. (2010). Systemic and intra-ozone therapy joint in arthritis of the temporomandibular joint from arthritis rheumatoid. CENIC Biol. Sci. 41, 169–172.
Menéndez, F., Díaz, G., and Menéndez, S. (1989). Ozone therapy in arthritis rheumatoid. CENIC Biol. Sci. 20, 144–151.
Menéndez, P., García, A., and Peláez, R. (2014). Absceso paravertebral e intraabdominal secundario a ozonoterapia por lumbalgia. Rev. Esp. Cir. Ortop. Traumatol. 58, 125–127. doi: 10.1016/j.recot.2013.06.003
Menéndez, S. A., González, R., Ledea, O. E., Hernández, F. A., León, O. S., and Díaz, M. F. (2008). Ozone Basic Aspects and Clinical Applications. Havana: CENIC.
Moretti, M. (2011). Effect of treatment with O2-O3 and hyaluronic acid in partial tear of the supraspinatus tendon. Riv. Ital. Ossigeno-Ozone Ther. 10:37.
Moretti, B., Lanzisera, R., Morese, A., Moretti, L., Patella, S., Patella, V., et al. (2004a). O2-O3 vs chondroprotectors in the treatment of osteoarthritis of the knee. Riv. Ital. Ossigeno-Ozone Ther. 3, 65–72.
Moretti, B., Lanzisera, R., Pesce, V., Moretti, L., Patella, S., and Patella, V. S. C. (2004b). O2-O3 vs. anti-inflammatory drugs in the treatment of neck pain. Riv. Ital. Ossigeno-Ozone Ther. 3, 131–137.
Moretti, B., Lanzisera, R., Sisti, G. L., Moretti, L., Patella, S., Patella, V., et al. (2005). O3 therapy in tendinopafhies and entrapment syndromes. Riv. Ital. Ossigeno-Ozone Ther. 4, 20–29.
Mustafa, Ç., Yunus, C., and Şakir, B. (2015). Myocardial infarction after ozone therapy: is ozone therapy Dr. Jekyll or Mr. Hyde? Cardiology 132, 101–104. doi: 10.1159/000431078
Muto, M. (2004). Intradiscal and intramuscular injection of oxygen – ozone: pathological evaluation. Work in Progress. Riv. Ital. Ossigeno-Ozone Ther. 3, 7–13.
Muto, M., Ambrosanio, G., Guarnieri, G., Capobianco, E., Piccolo, G., Annunziata, G., et al. (2008). Low back pain and sciatica: treatment with intradiscal-intraforaminal O2-O3 injection. Our experience. Radiol. Med. 113, 695–706. doi: 10.1007/s11547-008-0302-5
Muto, M., Giurazza, F., Silva, R. P., and Guarnieri, G. (2016). Rational approach, technique and selection criteria treating lumbar disk herniations by oxygen–ozone therapy. Interv. Neuroradiol. 22, 736–740. doi: 10.1177/1591019916659266
Noori-Zadeh, A., Bakhtiyari, S., Khooz, R., Haghani, K., and Darabi, S. (2019). Intra-articular ozone therapy efficiently attenuates pain in knee osteoarthritic subjects: a systematic review and meta-analysis. Complement. Ther. Med. 42, 240–247. doi: 10.1016/j.ctim.2018.11.023
OzoneSolution (2021). Ozone Compatible Materials. Hull (IO): OzoneSolutions. Available at: https://ozonesolutions.com/blog/ozone-compatible-materials/ (Accessed November 30, 2021).
Padilla del Rey, M. L., García Fernández, M. R., García Sánchez, F., Rastrollo Peña, D., Díaz-Alejo Marchante, C., and Gonzálvez Ortega, J. J., et al. (2015). “Ozone therapy in failed back surgery syndrome.” in 21st Annual Meeting ESRA. September 30 - October 2, 2015; Mallorca, Spain.
Palanca-Sánchez, I., Puig-Riera de Conías, M. M., Elola-Somoza, J., Bernal-Sobrino, J. L., and Paniagua Caparrós, J. L. (2011). Grupo de Expertos. Unidad de tratamiento de dolor: estándares y recomendaciones. Madrid: Ministerio de Sanidad, Política Social e Igualdad. Available at: https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/docs/EERR/Unidad_de_tratamiento_del_dolor.pdf (Accessed November 30, 2021).
Paoloni, M., Di Sante, L., Cacchio, A., Apuzzo, D., Marotta, S., Razzano, M., et al. (2009). Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine 34, 1337–1344. doi: 10.1097/BRS.0b013e3181a3c18d
Peralta, C., Xaus, C., Bartrons, R., Leon, O. S., Gelpí, E., and Roselló-Catafau, J. (2000). Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic. Res. 33, 595–605. doi: 10.1080/10715760000301121
Pressman, S. (2021). The story of ozone - 6th edition [Internet]. Santa Barbara Ca: Ozone Therapies Group; 2019 Oct [cited 2021 Nov 30]. Available from: https://www.ozonetherapiesgroup.com/ozone-research/2019/10/28/the-story-of-ozone-6th-edition
Qing, H., Feng, D., Tao, L., Hui, L., Fang, L. X., and Dong, L. (2005). Report on 602 cases of percutaneous ozone puncture chemonucleolysis treating lumbar disc protrusion. Riv. Ital. Ossigeno-Ozone Ther. 4, 145–148.
Raeissadat, S. A., Tabibian, E., Rayegani, S. M., Rahimi-Dehgolan, S., and Babaei-Ghazani, A. (2018). An investigation into the efficacy of intra-articular ozone (O2-O3) injection in patients with knee osteoarthritis: a systematic review and meta-analysis. J. Pain Res. 11, 2537–2550. doi: 10.2147/JPR.S175441
Re, L., Sanchez, G. M., and Mawsouf, N. (2010). Clinical evidence of ozone interaction with pain mediators. Saudi Med. J. 31, 1363–1367.
Salvatore, A., Valente, C., De Benedetti, G., and Caramello, G. (2016). Transient cortical blindness after intradiscal oxygen–ozone therapy. Indian J. Ophthalmol. 64:944. doi: 10.4103/0301-4738.198858
Sánchez, I., Ferrero, A., Aguilar, J. J., Conejero, J. A., Flórez, M. T., Arrebola, A., et al. (2006). SERMEF Manual of Rehabilitation and Physical Medicine. Madrid: Panamerican Medical.
Schwartz, E. S., Kim, H. Y., Wang, J., Lee, I., Klann, E., Chung, J. M., et al. (2009). Persistent pain is dependent on spinal mitochondrial antioxidant levels. J. Neurosci. 29, 159–168. doi: 10.1523/JNEUROSCI.3792-08.2009
Sconza, C., Respizzi, S., Virelli, L., Vandenbulcke, F., Iacono, F., Kon, E., et al. (2020). Oxygen-ozone therapy for the treatment of knee osteoarthritis: a systematic review of randomized controlled trials. Arthroscopy 36, 277–286. doi: 10.1016/j.arthro.2019.05.043
Seyman, D., Sepin, N., Inan, D., Ongu, G., and Ogunc, D. (2012). Pseudomonas aeruginosa septic arthritis of knee after intra-articular ozone injection. New Microbiol. 35, 345–348.
Siemsen, C. H. (1995). Ozon-Anwendung bei akuten und chronischen Gelenkerkrankungen. Ozon-Handbuch. Grundlagen. Prävention. Therapie. Landsberg: Ecomed.
SIGN (2019). Management of Chronic Pain. (SIGN Publication no. 136). Edinburgh: SIGN. Available at: https://www.sign.ac.uk/media/1108/sign136_2019.pdf (Accessed November 30, 2021)
Steppan, J., Meaders, T., Muto, M., and Murphy, K. J. (2010). A metaanalysis of the effectiveness and safety of ozone treatments for herniated lumbar discs. J. Vasc. Interv. Radiol. 21, 534–548. doi: 10.1016/j.jvir.2009.12.393
Torres, L. M., Terrero, M. J., Vidal, M., Aragón, F., and Martínez, J. (2009). Discolysis with intradiscal ozone in the treatment of sciatica due to herniated discs. Follow-up of 100 patients in 24 months. Rev. Soc. Esp. Dolor. 16, 147–152. doi: 10.1016/S1134-8046(09)71006-7
Trenti, G. F., and Gheza, G. (2002). Efficacy of oxygen-ozone pain therapy associated with shock waves to treat calcifying tendinitis of the shoulder. Preliminary findings. Riv. Ital. Ossigeno-Ozone Ther. 1, 45–50.
Vanni, D., Galzio, R., Kazakova, A., Pantalone, A., Sparvieri, A., Salini, V., et al. (2015). Intraforaminal ozone therapy and particular side effects: preliminary results and early warning. Acta Neurochir. 158, 491–496. doi: 10.1007/s00701-015-2545-y
Verga, C. (1989). Nuovo therapeutic approccio alle ernie e protrusioni discali lombari. Riv. Neuroradiol. 2:148. doi: 10.1177/19714009890020S139
Vilas-Rolan, D., Mila, M., Cuberas, G., Becerra, J. L., Herva, J. V., Massuet, A., et al. (2012). Neurological symptoms following exposure to ozone. J. Neurol. 259, 2740–2742. doi: 10.1007/s00415-012-6667-3
Villa, G. (2002). C6-C7 herniated disc treatment with paravertebral oxygen-ozone infiltration. Riv. Ital. Ossigeno-Ozone Ther. 1, 199–201.
Wang, M. C., Chan, L., Maiman, D. J., Kreuter, W., and Deyo, R. A. (2007). Complications and mortality associated with cervical spine surgery for degenerative disease in the United States. Spine 32, 342–347. doi: 10.1097/01.brs.0000254120.25411.ae
Wen-Juan, T., Long, J., Ying, W., and Ze-Min, K. (2017). Ozone therapy induced sinus arrest in a hypertensive patient with chronic kidney disease: a case report. Medicine 96:e9265.
Xiao, Y. Y., Tian, J. L., Li, J. K., and Zhang, J. S. (2006). CT guided ozone injection for the treatment of cervical disc herniation. Riv. Ital. Ossigeno-Ozone Ther. 5, 109–115.
Yang, C. S., Zhang, L. J., Sun, Z. H., Yang, L., and Shi, F. D. (2018). Acute prevertebral abscess secondary to intradiscal oxygen–ozone chemonucleolysis for treatment of a cervical disc herniation. Int. J. Med. Res. 46, 2461–2465. doi: 10.1177/0300060518764186
Zambello, A., Bianchi, M., and Bruno, F. (2004). Sicurezza in ozone therapy. Riv. Ital. Ossigeno-Ozone Ther. 3, 25–34.
Zambello, A., Fara, B., Tabaracci, G., and Bianchi, M. (2006). Epidural steroid injection vs paravertebral O2-O3 infiltration for symptomatic herniated disc refractory to conventional treatment: a prospective randomized study. Riv. Ital. Ossigeno-Ozone Ther. 5, 123–127.
Keywords: ozone therapy, ozone injections, medical ozone, pain medicine, chronic pain
Citation: Hidalgo-Tallón FJ, Torres-Morera LM, Baeza-Noci J, Carrillo-Izquierdo MD and Pinto-Bonilla R (2022) Updated Review on Ozone Therapy in Pain Medicine. Front. Physiol. 13:840623. doi: 10.3389/fphys.2022.840623
Edited by:
Emma Borrelli, University of Siena, ItalyReviewed by:
Enrico M. Camporesi, USF Health, United StatesMarko Samardžija, University of Zagreb, Croatia
Copyright © 2022 Hidalgo-Tallón, Torres-Morera, Baeza-Noci, Carrillo-Izquierdo and Pinto-Bonilla. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Francisco Javier Hidalgo-Tallón, fjht63@gmail.com